Platelet-activating factor induces the processing of nuclear factor-κB p105 into p50, which mediates acute bowel injury in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 1, 2009, Pages

  Liu, Shirley X L ^a   Tian, Runlan ^a   Baskind, Heather ^a   Hsueh, Wei ^a   De Plaen, Isabelle G ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Intestine; Necrotizing enterocolitis

Indexed keywords

CXCL2 CHEMOKINE; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; NUCLEAR FACTOR KAPPA B P105; NUCLEAR FACTOR KAPPA B P50; NUCLEAR FACTOR KAPPA B P52; THROMBOCYTE ACTIVATING FACTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CAROTID ARTERY; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; INFLAMMATION; INTESTINE INJURY; INTESTINE PERFUSION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; SHOCK; SMALL INTESTINE; SURVIVAL; UPREGULATION; WILD TYPE;

ANIMALS; CHEMOKINE CXCL2; DISEASE MODELS, ANIMAL; HYPOTENSION; I-KAPPA B PROTEINS; ILEUM; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; PLATELET ACTIVATING FACTOR; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPLANCHNIC CIRCULATION; TIME FACTORS; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 67650093193     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00053.2009     Document Type: Article

References (43)

1. Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K, Moriwaki T, Ishibashi R, Nozaki K, Morishita R, Hashimoto N. NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation 116: 2830-2840, 2007.
2. Boland MP, O'Neill LA. Ceramide activates NFkappaB by inducing the processing of p105. J Biol Chem 273: 15494-15500, 1998.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
4. Caplan MS, Hedlund E, Adler L, Lickerman M, Hsueh W. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol Nutr 24: 296-301, 1997.
5. De Plaen IG, Tan XD, Chang H, Qu XW, Liu QP, Hsueh W. Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. Biochim Biophys Acta 1392: 185-192, 1998.
6. De Plaen IG, Tan XD, Chang H, Wang L, Remick DG, Hsueh W. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. Br J Pharmacol 129: 307-314, 2000.
7. De Plaen IG, Qu XW, Wang H, Tan XD, Wang L, Han XB, Rozenfeld RA, Hsueh W. Endotoxin, but not platelet-activating factor, activates nuclear factor- kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. Immunology 106: 577-583, 2002.
8. De Plaen IG, Han XB, Liu X, Hsueh W, Ghosh S, May MJ. Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor. Immunology 118: 153-163, 2006.
9. De Plaen IG, Liu SX, Tian R, Neequaye I, May MJ, Han XB, Hsueh W, Jilling T, Lu J, Caplan MS. Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 61: 716-721, 2007.
10. Deryckere F, Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16: 405, 1994.
11. Duckworth EA, Butler T, Collier L, Collier S, Pennypacker KR. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res 1088: 167-175, 2006.
12. Erdman S, Fox JG, Dangler CA, Feldman D, Horwitz BH. Typhlocolitis in NF-kappa B-deficient mice. J Immunol 166: 1443-1447, 2001.
13. Frantz S, Hu K, Bayer B, Gerondakis S, Strotmann J, Adamek A, Ertl G, Bauersachs J. Absence of NF-κB subunit p50 improves heart failure after myocardial infarction. FASEB J 20: 1918-1920, 2006.
14. Frantz S, Tillmanns J, Kuhlencordt PJ, Schmidt I, Adamek A, Dienesch C, Thum T, Gerondakis S, Ertl G, Bauersachs J. Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. Am J Pathol 171: 507-512, 2007.
15. Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev 7: 1354-1363, 1993.
16. Gadjeva M, Tomczak MF, Zhang M, Wang YY, Dull K, Rogers AB, Erdman SE, Fox JG, Carroll M, Horwitz BH. A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol 173: 5786-5793, 2004.
17. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998.
18. Han XB, Liu X, Hsueh W, De Plaen IG. Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor. Am J Physiol Gastrointest Liver Physiol 287: G1220-G1226, 2004.
19. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 18: 2195-2224, 2004.
20. Hsueh W, De Plaen IG, Caplan MS, Qu XW, Tan XD, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical aspects, experimental models and pathogenesis. World J Pediatr 3: 17-29, 2006.
21. Hsueh W, Gonzalez-Crussi F, Arroyave JL. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1: 403-405, 1987.
22. Hsueh W, Gonzalez-Crussi F, Arroyave JL. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am J Pathol 122: 231-239, 1986.
23. Hsueh W, Sun X, Rioja LN, Gonzalez-Crussi F. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. Immunology 70: 309-314, 1990.
24. Huang L, Tan X, Crawford SE, Hsueh W. Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. Immunology 83: 65-69, 1994.
25. Kanters E, Gijbels MJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH, de Winther MP. Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 103: 934-940, 2004.
26. Kawamura N, Kubota T, Kawano S, Monden Y, Feldman AM, Tsutsui H, Takeshita A, Sunagawa K. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy. Cardiovasc Res 66: 520-529, 2005.
27. Kawano S, Kubota T, Monden Y, Tsutsumi T, Inoue T, Kawamura N, Tsutsui H, Sunagawa K. Blockade of NF-κB improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 291: H1337-H1344, 2006.
28. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD. Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway. J Biol Chem 270: 14928-14934, 1995.
29. Kubes P, Suzuki M, Granger DN. Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. Am J Physiol Gastrointest Liver Physiol 258: G158-G163, 1990.
30. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734, 2002.
31. Mizgerd JP, Lupa MM, Kogan MS, Warren HB, Kobzik L, Topulos GP. Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia. Am J Respir Crit Care Med 168: 810-817, 2003.
32. Mizgerd JP, Lupa MM, Spieker MS. NF-kappaB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation. BMC Immunol 9: 5-10, 2004.
33. Mozes T, Braquet P, Filep J. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Physiol Regul Integr Comp Physiol 257: R872-R877, 1989.
34. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2: 998-1004, 1996.
35. Qu XW, Rozenfeld RA, Huang W, Crawford SE, Gonzalez-Crussi F, Hsueh W. Interaction of platelet-activating factor, spleen, and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. J Physiol 512: 227-234, 1998.
36. Sobhani I, Hochlaf S, Denizot Y, Vissuzaine C, Rene E, Benveniste J, Lewin MM, Mignon M. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut 33: 1220-1225, 1992.
37. Sun XM, Hsueh W. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice. J Immunol 147: 509-514, 1991.
38. Tan X, Sun X, Gonzalez-Crussi FX, Gonzalez-Crussi F, Hsueh W. PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCR. Biochim Biophys Acta 1215: 157-162, 1994.
39. Tan XD, Wang H, Gonzalez-Crussi FX, Chang H, Gonzalez-Crussi F, Hsueh W. Platelet activating factor and endotoxin increase the enzyme activity and gene expression of type II phospholipase A2 in the rat intestine. Role of polymorphonuclear leukocytes. J Immunol 156: 2985-2990, 1996.
40. Thyssen E, Turk J, Bohrer A, Stenson WF. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis. Lipids 31, Suppl: S255-S259, 1996.
41. Wallace JL, Hogaboam CM, McKnight GW. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 259: G140-G146, 1990.
42. Wallace JL, Steel G, Whittle BJ, Lagente V, Vargaftig B. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology 93: 765-773, 1987.
43. Wang H, Tan X, Chang H, Gonzalez-Crussi F, Remick DG, Hsueh W. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. Biochem J 322: 603-608, 1997.